FDA faces backlash over approval of genetic test for opioid addiction risk

NBC News | April 4, 2024


In a letter to the agency, a group of experts, including Andy Saxon, MD, called on the commissioner to revoke its approval, saying the test doesn’t work. The FDA says the main risk associated with the test is false positives and false negatives.